Medindia

X

Revision: Ziehm Imaging and BrainLAB Announce Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS)

Friday, October 5, 2007 General News J E 4
Advertisement
NUREMBERG, Germany and MUNICH, Germany, Sept. 26 ZiehmImaging, a provider of mobile imaging solutions for healthcare, and BrainLAB,a manufacturer of software-driven systems for targeted, less-invasive medicaltreatments, have announced a development and marketing agreement for theintegration of mobile 3D C-arms and CAS (Computer Assisted Surgery).

In 2002, Ziehm Imaging and BrainLAB jointly pioneered the development ofDICOM-based CAS on 2D fluoroscopic images. Now, both companies will establishfull compatibility of Vision Vario 3D and Vision 3D -- Ziehm Imaging's C-arms-- with all mobile BrainLAB platforms for 3D intra-operative imaging.

The combination of both technologies will give surgeons better orientationin the OR and enable minimally invasive surgeries with less radiation andhigher accuracy. Vision Vario 3D, Vision 3D and BrainLAB CAS platforms aredesigned to assist with a broad variety of medical procedures, including spineand trauma, craniomaxillofacial, and neurosurgery.

Vision Vario 3D and Vision 3D allow surgeons to create a volumetric 3Ddataset with arbitrary numbers of fluoroscopic images. Depending on eachindication, the surgeon can define the image quality and the resolution of theimages.

BrainLAB technology makes it possible to automatically registerintra-operatively acquired 3D datasets. This means surgeons can uploaddatasets into the CAS system without the need for additional manual steps.During surgery, the position of the patient and the surgical instruments aretracked in real time through BrainLAB software.

"We are pleased to announce a partnership with BrainLAB, a worldwideestablished IGS vendor. Our installation base in Europe and customers all overthe world will benefit from the combination of outstanding technology inimaging and CAS," said Martin Herzmann, Director Global Marketing with ZiehmImaging.

Dr. Claus Schaffrath, Director Marketing Orthopedic Solutions withBrainLAB, commented: "We see the market for 3D intra-operative imaging gainingsignificant momentum. Customer demand clearly indicates the value of anergonomic combination of imaging and navigation, which leads to reducedradiation, increased precision and ultimately improved outcomes. Bycooperating with Ziehm Imaging we are strengthening our position in thismarket."

About Ziehm Imaging

Ziehm Imaging specializes in the development, manufacturing and worldwidemarketing of mobile x-ray-based imaging solutions. The company has been themarket leader in Germany for more than seven years, and in many other Europeancountries for the past two years. Today, Ziehm Imaging is a global systemsprovider, employing 190 people in Germany and 60 in the USA.

Extensive in-house development know-how is reflected in the Ziehm C-arms'high medical imaging performance, intelligent generator technology,significant dose savings and seamless digital network integration.Building on competence and creativity, as well as continuous dialog and closecooperation with renowned universities, research centers and hospitals, ZiehmImaging has developed groundbreaking technologies that have made the company aglobal trendsetter in intelligent interventional imaging.

Ziehm Imaging products are known for their outstanding versatility andeasy handling for a wide variety of medical applications. In addition, theyoffer seamless integration into existing IT environments for digital imagedata acquisition, image evaluation and image management.For more information, visit http://www.ziehm.com

About BrainLAB

BrainLAB develops, manufactures and markets software-driven medicaltechnology that enables procedures that are more precise, less invasive, andtherefore less expensive than traditional treatments. Among the core productsare image-guided systems that provide highly accurate real-time informationused for navigation during surg
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Launch of New Educational Campaign, Spread the Wor...
S
NexGenix Pharmaceuticals Enters into Exclusive Wor...